U.S. Communications Stock News

NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Rigetti Computing (RGTI) Stock Could Be 33.5% Overvalued After $100 Million Commerce Funding Letter

Rigetti Computing (RGTI) drew fresh attention after securing a letter of intent with the U.S. Department of Commerce for up to $100 million over three years to advance superconducting quantum computing. See our latest analysis for Rigetti Computing. Rigetti Computing’s share price has been volatile, with a 1-day share price return of 5.51% around the funding announcement but a 30-day share price return down 19.15%. Its 1-year total shareholder return is 97.96%, and its 3-year total...
NYSE:CQP
NYSE:CQPOil and Gas

Cheniere Energy Partners (CQP) Stock Can Its Valuation Hold Up After The $1.75b Notes Sale

Cheniere Energy Partners (CQP) has drawn fresh investor attention after closing a US$1.75b private placement of senior notes, prompting a closer look at how its funding choices interact with LNG demand and existing contracts. See our latest analysis for Cheniere Energy Partners. At a share price of US$58.05, Cheniere Energy Partners has seen short term share price pressure, with the stock down 8.42% over 30 days and 17.24% over 90 days. Its 5 year total shareholder return of 89.63% points to...
NasdaqGS:CBRL
NasdaqGS:CBRLHospitality

Cracker Barrel Old Country Store (CBRL) Stock Could Be 51% Overvalued After Guidance And Earnings

Cracker Barrel Old Country Store (CBRL) is back in focus after updated 2026 revenue guidance, fresh quarterly results, and a confirmed dividend, even as technical signals highlight strong buying momentum in the stock. See our latest analysis for Cracker Barrel Old Country Store. Cracker Barrel Old Country Store’s recent guidance, stronger quarterly earnings and confirmed dividend have arrived alongside a sharp shift in sentiment, with a 30 day share price return of 46.16% and a 90 day share...
NYSE:U
NYSE:USoftware

Unity Software (U) Stock Could Be 20.1% Undervalued After Piper Sandler Backs AI Growth

Piper Sandler’s bullish update on Unity Software (U) centers on progress in its Grow segment and the AI-powered advertising platform Vector, which the firm links to improved confidence in the company’s longer term financial potential. See our latest analysis for Unity Software. Unity Software’s share price has been volatile, with a 51.49% 90 day share price return contrasting with a decline of 37.90% year to date. The 1 year total shareholder return sits at 17.94%, suggesting momentum has...
NYSE:AVB
NYSE:AVBResidential REITs

3 US Stocks For 2026 Rate Hikes And Funding Risk

With Wall Street now bracing for potential rate hikes in 2026 instead of cuts, interest rate sensitivity has jumped back to the top of the checklist for many stock pickers. Persistent 4.2% inflation, a firm labor market, and a hawkish Federal Reserve are reshaping which companies could benefit from higher yields, and which might feel the strain of rising borrowing costs and pressure on real estate and credit. This article breaks down three stocks exposed to that story, spotlighting two that...
NYSE:QTWO
NYSE:QTWOSoftware

Is Rising Institutional Ownership and AI Focus Altering The Investment Case For Q2 Holdings (QTWO)?

Q2 Holdings recently presented at the Strategic Growth Conference 2026 in Cleveland, highlighting its digital banking platform and growth initiatives to investors. Behind the scenes, very large institutional ownership and rising stakes from firms like BlackRock and Wellington point to intensifying professional investor interest in Q2’s story. We’ll now examine how growing institutional ownership reshapes Q2 Holdings’ existing investment narrative built around digital banking and AI...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Evercore ISI’s Optical AI Call Could Be A Game Changer For Credo Technology Group Holding (CRDO)

Earlier this week, Evercore ISI initiated coverage of Credo Technology Group Holding with an Outperform rating, emphasizing its move beyond copper-based AI connectivity into optical DSPs and silicon photonics following the DustPhotonics acquisition. This coverage spotlighted how Credo’s expanded optical portfolio and vertically integrated technology stack could materially reshape its role in future AI data-center networking architectures. With this backdrop, we’ll now examine how Evercore’s...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Partners With JD.com To Push AI Buying And Cross Border Commerce

Mastercard and JD.com have agreed to a new partnership focused on payment infrastructure, cross-border commerce, and AI-supported purchasing. The collaboration targets areas such as fraud prevention, SME supply chain finance, and co-branded card programs. This development positions Mastercard to deepen its role in digital commerce across Asia and within JD.com’s ecosystem. Mastercard, traded on NYSE:MA, is adding another major ecommerce partner as it looks to remain central to global...
NasdaqGS:CSIQ
NasdaqGS:CSIQSemiconductor

Canadian Solar (CSIQ) Stock Could Be 8.3% Undervalued After TOPCon 3.0 Launch

Canadian Solar (CSIQ) has drawn fresh attention after unveiling its TOPCon 3.0 high-power-density photovoltaic module, a product aimed at large utility projects and commercial or industrial rooftops worldwide. See our latest analysis for Canadian Solar. The TOPCon 3.0 announcement arrives after a mixed period for Canadian Solar, with the share price at US$16.27, a 30 day share price return down 13.82% but a 90 day share price return up 22.7%. The 1 year total shareholder return is 60.61%,...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

KLA (KLAC) Stock Could Be 30% Overvalued After AI Demand Fuels Analyst Optimism

KLA (KLAC) drew fresh attention after announcing a ten-for-one stock split, paired with stronger AI-driven semiconductor demand and rising institutional interest. This has prompted many investors to reassess the stock’s recent performance and valuation. See our latest analysis for KLA. Recent gains have been sharp, with KLA’s share price up 8.73% in the last session, 37.45% over 30 days and 103.66% year to date. Its 1 year total shareholder return of 205.08% and 5 year total shareholder...
NYSE:SIG
NYSE:SIGSpecialty Retail

Did Analyst Upgrade and Value Score Just Shift Signet Jewelers' (SIG) Investment Narrative?

Recently, Signet Jewelers received a favorable Zacks Rank #2 (Buy) and an A grade for value, reflecting valuation metrics that compare attractively with industry averages. This recognition highlights how analyst views on Signet’s earnings outlook and perceived undervaluation are becoming an increasingly important part of the investment story. We’ll now examine how this positive analyst stance on Signet’s valuation and earnings outlook aligns with, or challenges, its existing investment...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

What BridgeBio Pharma (BBIO)'s New Phase 3 Infigratinib Data Reveal About Its Rare Disease Strategy

BridgeBio Pharma announced that it will present additional positive data from its pivotal Phase 3 PROPEL 3 trial of oral infigratinib in children with achondroplasia, along with multiple clinical and quality-of-life studies in skeletal dysplasias and autosomal dominant hypocalcemia, at the International Congress of Children’s Bone Health 2026 in Montreal. By pairing late-breaking Phase 3 efficacy data with real-world quality-of-life, early intervention, and disease-burden findings, BridgeBio...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

CoreWeave (CRWV) Stock Could Be 68.5% Overvalued as AI Infrastructure Questions Linger

CoreWeave (CRWV) has drawn fresh attention after recent trading, with the stock closing at $117.95. Investors are weighing this move alongside the company’s role in providing cloud infrastructure for artificial intelligence workloads. See our latest analysis for CoreWeave. That US$117.95 close caps a strong run, with a 1 day share price return of 2.38% and a 90 day share price return of 42.07%. However, the 1 year total shareholder return is down 32.09%, so momentum in CoreWeave’s share price...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is Nasdaq-100 Inclusion and AI Defense Tailwinds Altering The Investment Case For Teradyne (TER)?

Teradyne was recently added to the Nasdaq-100 Index, while simultaneously benefiting from heightened demand for its semiconductor test equipment and robotics tied to AI infrastructure and defense applications. Alongside its index inclusion, Teradyne’s multi-year U.S. Air Force contract and collaboration with Tokyo Electron highlight its role in enabling AI-focused semiconductor testing. We’ll now explore how Teradyne’s Nasdaq-100 inclusion could influence its investment narrative built...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies (TSHA) Stock Could Be 47.5% Undervalued After Rett Trial Progress

Taysha Gene Therapies (TSHA) has drawn fresh attention after completing patient dosing in its pivotal REVEAL trial of TSHA-102 for Rett syndrome and sharing longer-term safety and functional outcome data. See our latest analysis for Taysha Gene Therapies. The Rett data release has arrived alongside a sharp shift in how the market prices Taysha Gene Therapies, with a 30 day share price return of 16.94% and a year to date share price return of 22.29%. The 1 year total shareholder return of...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Golar LNG (GLNG) Stock Could Be 18% Undervalued on Its FLNG Backlog Story

Golar LNG (NasdaqGS:GLNG) has attracted fresh attention after recent share price moves, with the stock trading around $49.60. Investors are weighing its liquefied natural gas infrastructure focus in relation to its mixed short term return figures. See our latest analysis for Golar LNG. Recent share price moves around $49.60 come after a year where Golar LNG’s share price return is up 30.70% year to date, while the 3 year total shareholder return of 170.90% and 5 year total shareholder return...
NYSE:TPB
NYSE:TPBTobacco

Turning Point Brands (TPB) Stock Could Be 36.9% Undervalued After Institutional Buying Jump

Turning Point Brands (TPB) is back in focus after recent data showed a sharp rise in institutional ownership, with investors such as BlackRock and Thrivent Asset Management expanding positions and helping lift the company to a leading position within the Food & Tobacco industry. See our latest analysis for Turning Point Brands. Turning Point Brands’ share price has been under pressure recently, with the stock down 8.86% over the past month and 25.60% year to date. At the same time, 1-year...
NYSE:REXR
NYSE:REXRIndustrial REITs

Rexford Industrial Realty (REXR) Stock Could Be 16.4% Undervalued After Scotiabank Upgrade

Rexford Industrial Realty (REXR) drew fresh attention after Scotiabank raised its recommendation on the stock, coinciding with rising institutional ownership and increased positioning by the company’s largest institutional shareholder. See our latest analysis for Rexford Industrial Realty. At a share price of $33.12, Rexford Industrial Realty has seen its 1 day share price return of 2.0% partially offset a weaker recent patch, with the 30 day share price return down 8.46% and the 1 year total...
NasdaqCM:ASTH
NasdaqCM:ASTHHealthcare

Is Astrana Health's (ASTH) ESOP Shelf Filing Quietly Reframing Its Value‑Based Care Narrative?

Astrana Health, Inc. recently filed a shelf registration for up to US$38.73 million, covering 1,000,000 shares of common stock for an ESOP-related offering. This move, coming alongside a recent analyst upgrade citing an improved outlook for value-based care, underscores Astrana’s focus on employee ownership and operational momentum. We’ll now examine how Barclays’ more constructive view on Astrana’s value-based care outlook may influence the company’s broader investment narrative. Explore 31...
NYSEAM:CMT
NYSEAM:CMTChemicals

3 US Industrial Stocks With Export Exposure And Margin Focus

Export oriented Indian industrials are in the spotlight as U.S. tariff decisions approach, with expiry of key import tariffs on July 24 and potential new Section 301 measures adding a fresh layer of uncertainty to India U.S. trade. For investors looking at this theme, the question is whether selected exporters with solid health and growth profiles can still offer resilient opportunities if policy turns less friendly. This article breaks down 3 stocks from the Export Oriented Indian...
NYSE:FLS
NYSE:FLSMachinery

Flowserve (FLS) Stock Could Be 1.6% Undervalued As Service Shift Draws Investor Attention

Flowserve (FLS) is back in focus as investors react to its greater push into higher margin service and digital monitoring offerings tied to critical energy and water infrastructure projects. See our latest analysis for Flowserve. Recent trading reflects that shift in focus, with the share price up 17.37% over the past 30 days and 15.48% year to date, while Flowserve’s 1 year total shareholder return of 78.44% and 3 year total shareholder return of 136.79% point to strong momentum rather than...
NYSE:VG
NYSE:VGOil and Gas

Venture Global (VG) Secures Expanded Europe LNG Deals With EnBW And Atlantic SEE

Venture Global (NYSE:VG) has signed new and expanded LNG supply agreements with Germany's EnBW and Greece’s Atlantic-SEE. The Atlantic-SEE contract has been doubled, increasing Venture Global's contracted LNG volumes into Europe. These agreements deepen the company's role as a U.S. LNG supplier to European utilities focused on long-term energy diversification. Venture Global is a U.S. liquefied natural gas exporter, and its latest deals with EnBW and Atlantic-SEE add fresh detail to how the...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Definium Therapeutics (DFTX) Stock Could Be 30.5% Undervalued After Positive Phase 3 Data

Definium Therapeutics (DFTX) reported that its Phase 3 Emerge trial of DT120 Orally Disintegrating Tablet in adults with major depressive disorder met the primary and all key secondary efficacy endpoints, highlighting clinically meaningful differences versus placebo. See our latest analysis for Definium Therapeutics. Definium Therapeutics’ positive Phase 3 Emerge data lands after a strong run in the stock, with a 30 day share price return of 8.8% and a 90 day share price return of 37.61%,...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Is Down 5.3% After ERAS-0015 Lawsuits Raise Data, Safety And IP Concerns

Erasca, Inc. is now the subject of multiple securities class action lawsuits alleging misleading statements about its lead oncology candidate ERAS-0015, including claims of undisclosed safety concerns, questionable efficacy comparisons, and heightened patent and trade secret risks, following disclosures made prior to today. The convergence of alleged data misrepresentation, intellectual property disputes with Revolution Medicines, and a reported patient death has turned ERAS-0015 from a core...